Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124262012 | 12426201 | 2 | F | 201504 | 20160701 | 20160601 | 20160707 | EXP | US-AMGEN-USASP2016069402 | AMGEN | 0.00 | Y | 0.00000 | 20160706 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124262012 | 12426201 | 1 | PS | NEULASTA | PEGFILGRASTIM | 1 | Unknown | UNK | U | 125031 | UNKNOWN FORMULATION | ||||||||
| 124262012 | 12426201 | 2 | C | TAXOTERE | DOCETAXEL | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124262012 | 12426201 | 1 | Invasive ductal breast carcinoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124262012 | 12426201 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124262012 | 12426201 | Arthralgia | |
| 124262012 | 12426201 | Back pain | |
| 124262012 | 12426201 | Deafness | |
| 124262012 | 12426201 | Depression | |
| 124262012 | 12426201 | Emotional disorder | |
| 124262012 | 12426201 | Mental disorder | |
| 124262012 | 12426201 | Mobility decreased | |
| 124262012 | 12426201 | Muscle twitching | |
| 124262012 | 12426201 | Pain |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |